Moderna files for U.S. authorization to use its COVID-19 vaccine in teens

Stock Markets25 minutes ago (Jun 10, 2021 09:41AM ET)

(C) Reuters. FILE PHOTO: A healthcare worker holds a vial of the Moderna COVID-19 Vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in Manhattan in New York City, New York, U.S., January 29, 2021.

(Reuters) – Moderna (NASDAQ:MRNA) Inc said on Thursday it has filed for U.S. authorization to use its COVID-19 vaccine in adolescents aged 12 through 17, potentially offering healthcare providers and pediatricians an easier-to-store shot ahead of the return-to-school season in the fall.

The company is the second drugmaker to seek regulatory nod for use of its vaccine in the age group, as the U.S. tries to vaccinate more young people.

Vaccinating children has been considered key to achieving “herd immunity” and while they mostly develop only mild COVID-19 symptoms or no symptoms, younger people still remain at risk of becoming seriously ill, and can spread the virus.

Moderna’s vaccine is already being used in the United States, the European Union and Canada for anyone over 18. The drugmaker said it has also submitted applications to European and Canadian regulators seeking authorization for the shot’s use in adolescents.

Last month, Moderna’s two-shot vaccine was shown to be effective in adolescents aged 12-17 and showed no new or major safety problems in a clinical trial which evaluated the vaccine in 3,732 teenagers.

The U.S. has already authorized Pfizer Inc (NYSE:PFE) and German partner BioNTech SE (NASDAQ:BNTX)’s COVID-19 vaccine for use in children as young as 12.

More than 7 million teens have received at least one dose of the vaccine in the United States, according to the U.S. Centers for Disease Control and Prevention.

Moderna files for U.S. authorization to use its COVID-19 vaccine in teens

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Stories

Discover

Soccer-Denmark’s Eriksen still in hospital, condition is stable

World45 minutes ago (Jun 13, 2021 05:20AM ET) (C) Reuters. FILE PHOTO: Soccer Football -...

Exclusive: Washington Prime to file bankruptcy as soon as...

Stock Markets51 minutes ago (Jun 13, 2021 05:15AM ET) (C) Reuters. By Mike Spector NEW YORK...

Israel’s Knesset set to vote on new government, ending...

5/5 (C) Reuters. FILE PHOTO: Israeli Prime Minister Benjamin Netanyahu speaks during a ceremony to...

Popular Categories